In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OPi Group

Division of EUSA Pharma
www.orphan-opi.com

Latest From OPi Group

EUSA Pharma Aims To Grow Through Acquisitions In Specialty Rx Market

EUSA Pharma announced the launch of operations March 23 with a group of products acquired from Jazz Pharmaceuticals and funding from equity investor Essex Woodlands; it is the third specialty pharma company set up by U.K. entrepreneur Bryan Morton.

BioPharmaceutical Europe

Start-Ups Against Inflammation

Inflammation plays a part in a wide range of diseases across a broad spectrum of markets, including the huge and already crowded, like rheumatoid arthritis; the difficult to navigate, like Crohn's disease; and the emerging, like atherosclerosis. Start-ups looking to compete in inflammation can boost their chances of success by focusing on niche indications or on drug targets with broad applicability, and thus attract the attention of in-licensers or acquirers. In this issue, we profile four young companies hoping to prove the worth of their technologies to investors and partners alike.
BioPharmaceutical

Europe's New Spec Pharma Models

Spec pharma has created significant value in the US, but not, so far, in Europe. Still, Europe's spec pharma hopefuls aren't giving up, and they're trying out variations on the theme--some starting with infrastructure, others with products.
Europe North America

Recent Dealmaking (5/2004)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Orphan Pharma International
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • EUSA Pharma
  • Senior Management
  • Gilles Alberici, Pres. & CEO
    Marie-Laure Pellotier, CFO
    Marc Moguilewsky, VP, Licensing, Sales & Mktg.
    Jean-Luc Bejot, VP, Dev.
  • Contact Info
  • OPi Group
    Phone: (33) 437 498 585
    6 chemin de l'Industrie
    Dardilly, 69570
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register